$ABEO
ABEONA THERAPEUTICS INC.

2019 Q1 Form 10-K Financial Statement

#000114420419014623 Filed on March 18, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018 Q3
Revenue $0.00 $480.0K $1.709M
YoY Change -100.0% 118.18% 680.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.660M $7.630M $4.970M
YoY Change 96.53% 145.34% 129.03%
% of Gross Profit
Research & Development $11.74M $9.470M $13.15M
YoY Change 43.8% 65.97% 301.28%
% of Gross Profit
Depreciation & Amortization $1.658M $1.390M $505.0K
YoY Change 852.87% 892.86% 265.94%
% of Gross Profit
Operating Expenses $11.74M $9.470M $13.15M
YoY Change 43.8% 65.97% 301.28%
Operating Profit -$19.05M -$18.01M -$16.92M
YoY Change 78.36% 105.83% 215.48%
Interest Expense $500.0K $530.0K $500.0K
YoY Change 233.33% 76.67% 2400.0%
% of Operating Profit
Other Income/Expense, Net $497.0K
YoY Change 2515.79%
Pretax Income -$18.56M -$17.48M -$16.42M
YoY Change 76.26% 106.86% 207.49%
Income Tax
% Of Pretax Income
Net Earnings -$18.56M -$17.48M -$16.42M
YoY Change 76.21% 106.85% 207.3%
Net Earnings / Revenue -3641.46% -960.74%
Basic Earnings Per Share
Diluted Earnings Per Share -$387.1K -$360.6K -$339.8K
COMMON SHARES
Basic Shares Outstanding 47.95M 47.94M shares 47.94M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $68.30M $85.00M $112.2M
YoY Change -48.26% -38.32% 98.58%
Cash & Equivalents $25.92M $18.75M $33.60M
Short-Term Investments $42.40M $66.20M $78.60M
Other Short-Term Assets $3.400M $3.800M $2.000M
YoY Change 61.9% 40.74% 11.11%
Inventory
Prepaid Expenses
Receivables $0.00 $100.0K $400.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $71.72M $88.85M $114.6M
YoY Change -46.54% -36.8% 96.15%
LONG-TERM ASSETS
Property, Plant & Equipment $10.36M $9.443M $9.245M
YoY Change 116.25% 587.26% 1220.71%
Goodwill $32.47M $32.47M $32.47M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.100M $600.0K $600.0K
YoY Change 175.0% 50.0% 500.0%
Total Long-Term Assets $94.42M $85.55M $46.03M
YoY Change 127.5% 124.1% 23.39%
TOTAL ASSETS
Total Short-Term Assets $71.72M $88.85M $114.6M
Total Long-Term Assets $94.42M $85.55M $46.03M
Total Assets $166.1M $174.4M $160.6M
YoY Change -5.42% -2.44% 67.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.189M $6.122M $10.33M
YoY Change -29.12% 225.47% 416.55%
Accrued Expenses $5.241M $3.936M
YoY Change 668.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.42M $20.35M $10.33M
YoY Change 794.94% 263.01% 297.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $26.90M $20.00M $0.00
YoY Change 545.16% -100.0%
Total Long-Term Liabilities $26.90M $20.00M $0.00
YoY Change 545.16% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.42M $20.35M $10.33M
Total Long-Term Liabilities $26.90M $20.00M $0.00
Total Liabilities $48.34M $40.35M $10.33M
YoY Change 1920.18% 365.55% 75.1%
SHAREHOLDERS EQUITY
Retained Earnings -$428.7M -$410.2M -$392.7M
YoY Change 21.28% 14.01%
Common Stock $546.5M $544.2M $543.0M
YoY Change 2.39% 2.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.8M $134.0M $150.2M
YoY Change
Total Liabilities & Shareholders Equity $166.1M $174.4M $160.6M
YoY Change -5.42% -2.44% 67.79%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$18.56M -$17.48M -$16.42M
YoY Change 76.21% 106.85% 207.3%
Depreciation, Depletion And Amortization $1.658M $1.390M $505.0K
YoY Change 852.87% 892.86% 265.94%
Cash From Operating Activities -$15.08M -$16.97M -$9.040M
YoY Change 269.38% 236.04% 33.53%
INVESTING ACTIVITIES
Capital Expenditures $1.226M -$10.91M -$1.660M
YoY Change -64.99% 1458.57% 1975.0%
Acquisitions
YoY Change
Other Investing Activities $24.00M $13.04M -$8.780M
YoY Change
Cash From Investing Activities $22.77M $2.120M -$10.43M
YoY Change -750.31% -402.86% 12937.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.00K 0.000 3.080M
YoY Change -98.47% -100.0% -39.13%
NET CHANGE
Cash From Operating Activities -15.08M -16.97M -9.040M
Cash From Investing Activities 22.77M 2.120M -10.43M
Cash From Financing Activities 28.00K 0.000 3.080M
Net Change In Cash 7.724M -14.85M -16.39M
YoY Change -234.21% -118.22% 815.64%
FREE CASH FLOW
Cash From Operating Activities -$15.08M -$16.97M -$9.040M
Capital Expenditures $1.226M -$10.91M -$1.660M
Free Cash Flow -$16.30M -$6.060M -$7.380M
YoY Change 114.98% 39.31% 10.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18750000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137750000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
66218000
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2018Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
81000
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
107000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3802000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2735000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
88851000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
140592000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9443000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1374000
CY2018Q4 abeo Other Assetsand Restricted Cash
OtherAssetsandRestrictedCash
597000
CY2017Q4 abeo Other Assetsand Restricted Cash
OtherAssetsandRestrictedCash
357000
CY2018Q4 us-gaap Assets
Assets
174399000
CY2017Q4 us-gaap Assets
Assets
178766000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6122000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1881000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3936000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
512000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20354000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5607000
CY2018Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3061000
CY2018Q4 us-gaap Liabilities
Liabilities
40354000
CY2017Q4 us-gaap Liabilities
Liabilities
8668000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
479000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
469000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
543754000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
529421000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-410188000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359792000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
174399000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178766000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
296000
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3214000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
134045000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
170098000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47944486
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46888108
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46888108
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47944486
CY2018Q4 abeo Payable Due Licensor Current
PayableDueLicensorCurrent
10000000
CY2017Q4 abeo Payable Due Licensor Current
PayableDueLicensorCurrent
0
CY2018Q4 abeo Payable Due Licensor Non Current
PayableDueLicensorNonCurrent
20000000
CY2017Q4 abeo Payable Due Licensor Non Current
PayableDueLicensorNonCurrent
0
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38698000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16989000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10655000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20106000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10943000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13290000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2360000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
741000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
825000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
61164000
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
28673000
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
24770000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-58166000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-27836000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-23881000
CY2018 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1506000
CY2017 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
525000
CY2016 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2014000
CY2018 abeo Interest And Other Expense
InterestAndOtherExpense
11000
CY2017 abeo Interest And Other Expense
InterestAndOtherExpense
8000
CY2016 abeo Interest And Other Expense
InterestAndOtherExpense
6000
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.19
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47528248
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41636752
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34180253
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
67721000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
99098000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4829000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4644000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8178000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
150000
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2452000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
350000
CY2016 abeo Stock Issued During Period Value Warrants Two Exercised
StockIssuedDuringPeriodValueWarrantsTwoExercised
0
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
344000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2244000
CY2018 abeo Stock Issued During Period Value Warrants Two Exercised
StockIssuedDuringPeriodValueWarrantsTwoExercised
3233000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-56671000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-27319000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-21873000
CY2018 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0
CY2017 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
127000
CY2016 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
0
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-26000
CY2017 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-17000
CY2016 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
9000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7665000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1301000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2819000
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2016 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-2591000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
296000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2009000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-602000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39111000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22655000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13014000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9243000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
860000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
519000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10251000
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
136092000
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2016 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
70500000
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85086000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-860000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-519000
CY2018Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9470000
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13150000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7916000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8162000
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7631000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4970000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4627000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2878000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-18010000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-16916000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12557000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10683000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-17479000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-16419000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-12243000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-10530000
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2018Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47944486
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47794394
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47303518
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47060523
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5706000
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3277000
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5808000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2198000
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3113000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2166000
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2642000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3022000
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8750000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5362000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8440000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5284000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-8450000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-5343000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-8279000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-5247000
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2017Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45598667
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40377890
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40270879
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40254679
CY2018 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0
CY2017 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
4000000
CY2016 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0
CY2018 abeo Significantnoncashtransactionvalueofsharesissued
Significantnoncashtransactionvalueofsharesissued
0
CY2017 abeo Significantnoncashtransactionvalueofsharesissued
Significantnoncashtransactionvalueofsharesissued
0
CY2016 abeo Significantnoncashtransactionvalueofsharesissued
Significantnoncashtransactionvalueofsharesissued
2452000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
11000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
8000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
6000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Results
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingResults
2067000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Diluted Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare
0.04
CY2018Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Results
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingResults
543000
CY2018Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Diluted Earnings Per Share
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnDilutedEarningsPerShare
0.01
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1067000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2580000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-160000
CY2018 abeo Increase Decrease In Other Assets And Restricted Cash
IncreaseDecreaseInOtherAssetsAndRestrictedCash
-40000
CY2017 abeo Increase Decrease In Other Assets And Restricted Cash
IncreaseDecreaseInOtherAssetsAndRestrictedCash
11000
CY2016 abeo Increase Decrease In Other Assets And Restricted Cash
IncreaseDecreaseInOtherAssetsAndRestrictedCash
4000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-11901000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-9289000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7437000
CY2018 abeo Incometax Reconciliation Current Year Reserve
IncometaxReconciliationCurrentYearReserve
11877000
CY2017 abeo Incometax Reconciliation Current Year Reserve
IncometaxReconciliationCurrentYearReserve
-25175000
CY2016 abeo Incometax Reconciliation Current Year Reserve
IncometaxReconciliationCurrentYearReserve
7423000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
24000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
46000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
14000
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
34418000
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38761000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
50029000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
3214000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
3227000
CY2018Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
3012000
CY2017Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
3089000
CY2018Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
72000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
28000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6316000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5122000
CY2018Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
57000
CY2017Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
57000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
62000
CY2017Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
778000
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
399000
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
379000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
0
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
156000
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
80000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
143000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
51715000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62838000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
51715000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
62838000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2018 us-gaap Other Noncash Income
OtherNoncashIncome
626000
CY2017 us-gaap Other Noncash Income
OtherNoncashIncome
0
CY2016 us-gaap Other Noncash Income
OtherNoncashIncome
0
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
184576000
CY2018Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
3214000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5477000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92403000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
42537000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-118720000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
68888000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29004000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138030000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69142000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40138000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19310000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2244000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
344000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
350000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0
CY2016 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
150000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8178000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4644000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4829000
CY2018 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
688000
CY2017 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
1272000
CY2016 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
3432000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
30000000
CY2017 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0
CY2016 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0
CY2017Q4 us-gaap Share Price
SharePrice
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
44859000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4608000
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1817000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
631000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
43042000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0262
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.11
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0181
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0110
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1820686
CY2016 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3432000
CY2017 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1272000
CY2018 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
6275000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
688000
CY2018 abeo Non Cash Or Part Non Cash Acquisition Non Cash Financial Or Equity Instrument Consideration Value Of Warrants Issued1
NonCashOrPartNonCashAcquisitionNonCashFinancialOrEquityInstrumentConsiderationValueOfWarrantsIssued1
0
CY2016Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.00
CY2016Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.00
CY2017Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5750000
CY2017Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
16.00
CY2017Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92000000
CY2016Q4 abeo New Issues Share Price Per Share
NewIssuesSharePricePerShare
3.27
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3977000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5378000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5378000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5378000
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-top: 0px; margin-right: 0px; margin-bottom: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;">Use of Estimates</div></div></div><div style="margin-bottom: 0px; margin-top: 0px; font-size: 6pt; background: none;"><div style="font-size: 6pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; margin-top: 0px; text-indent: 0.28in; margin-right: 0px; margin-bottom: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;times new roman&quot;, times, serif; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amount of assets and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reported period. Actual results could differ from these estimates and assumptions. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7662491
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8364412
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8508177
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
445125000
CY2018 dei Trading Symbol
TradingSymbol
ABEO
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47949694
CY2018 dei Entity Shell Company
EntityShellCompany
false
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5378000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
5378000
CY2018Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
16152000
CY2018 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
18500
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
18000
CY2016 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
18000
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
317000
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
0
CY2018 abeo Number Of Investment Options
NumberOfInvestmentOptions
50
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1186000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
534000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
677000
CY2018Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
85000000
CY2018Q4 us-gaap Goodwill
Goodwill
32466000
CY2017Q4 us-gaap Goodwill
Goodwill
32466000
CY2018 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2018Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
409000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1735000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1708000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1722000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1736000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1751000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3546000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
12198000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1297000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
742000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
548000
CY2017Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
455000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11003000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1760000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1560000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
386000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1174000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
207000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
148000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
66218000
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Entity Registrant Name
EntityRegistrantName
ABEONA THERAPEUTICS INC.
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0000318306
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2018 dei Entity Small Business
EntitySmallBusiness
true
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2393000
CY2018Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2018Q1 us-gaap Liabilities
Liabilities
2393000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-353517000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
176373000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
280000
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018 us-gaap Revenues
Revenues
2998000
CY2017 us-gaap Revenues
Revenues
837000
CY2016 us-gaap Revenues
Revenues
889000
CY2018Q4 abeo New Issues Share Price Per Share
NewIssuesSharePricePerShare
CY2017Q4 abeo New Issues Share Price Per Share
NewIssuesSharePricePerShare
CY2018 abeo Lease Extension Period
LeaseExtensionPeriod
P5Y
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69142000
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
560000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
280000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0
CY2018Q4 abeo Cash And Cash Equivalents Restricted Cash
CashAndCashEquivalentsRestrictedCash
19310000
CY2017Q4 abeo Cash And Cash Equivalents Restricted Cash
CashAndCashEquivalentsRestrictedCash
138030000
CY2016Q4 abeo Cash And Cash Equivalents Restricted Cash
CashAndCashEquivalentsRestrictedCash
69142000
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018

Files In Submission

Name View Source Status
0001144204-19-014623-index-headers.html Edgar Link pending
0001144204-19-014623-index.html Edgar Link pending
0001144204-19-014623.txt Edgar Link pending
0001144204-19-014623-xbrl.zip Edgar Link pending
abeo-20181231.xml Edgar Link completed
abeo-20181231.xsd Edgar Link pending
abeo-20181231_cal.xml Edgar Link unprocessable
abeo-20181231_def.xml Edgar Link unprocessable
abeo-20181231_lab.xml Edgar Link unprocessable
abeo-20181231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv515695-10k.htm Edgar Link pending
tv515695-exh21.htm Edgar Link pending
tv515695-exh23x1.htm Edgar Link pending
tv515695-exh31x1.htm Edgar Link pending
tv515695-exh31x2.htm Edgar Link pending
tv515695-exh32.htm Edgar Link pending
tv515695_chrt-line1.jpg Edgar Link pending
tv515695_chrt-line2.jpg Edgar Link pending
tv515695_chrt-pipline.jpg Edgar Link pending
tv515695_ex10-18.htm Edgar Link pending
tv515695_ex3-2.htm Edgar Link pending
tv515695_img1.jpg Edgar Link pending